In India, a diagnosis of end-stage renal disease often means a long, expensive journey to a distant city. For patients in Tier II and III cities, the nearest dialysis center can be hours away, a logistical and financial burden that can be as debilitating as the disease itself. The Renal Project, a Mumbai-based startup founded in 2019, is betting that a network of small, standardized dialysis centers can change that arithmetic, one two-bed clinic at a time.
Founded by Shashank Moddhia, a biomedical engineer with a quality assurance background at Baxter International and Philips Healthcare, the company is taking a service-first, infrastructure-heavy approach to a critical healthcare gap. It operates a growing network of dialysis centers and clinics, supplying the machines, staff, and management for hemodialysis. While many healthtech startups chase software margins, The Renal Project's wedge is physical presence, aiming to make life-sustaining treatment accessible and affordable outside of major metropolitan hubs [CB Insights-style profile, January 2024].
From quality assurance to care delivery
Shashank Moddhia's path to founding The Renal Project was not through clinical practice, but through the rigorous systems of medical device manufacturing. After graduating from the University of Texas with a degree in biomedical engineering, he spent over six years in quality assurance roles across the Asia Pacific region, most recently as a manager at Baxter, a global leader in renal care. This experience with ISO 9001:2015 standards and large-scale medical operations informs the company's operational model. The entire operation is structured according to sections and guidelines of the Indian Society of Nephrology, aiming for a replicable, quality-controlled template.
"I launched The Renal Project in 2019 after quitting my job with Baxter International," Moddhia stated in an interview, framing the move as a shift from ensuring product quality to addressing a systemic delivery failure. The founder's background suggests a focus on operational scalability and compliance, critical for a capital-intensive business navigating India's complex healthcare regulatory environment.
The capital-intensive wedge of physical access
The company's fundamental bet is that expanding physical infrastructure is the primary bottleneck to care. Its model involves setting up micro-centers, scalable from as few as two beds upwards, and collaborating with existing medical facilities to 'fill the gap' where dialysis services are unavailable. It also lists home-based treatment solutions as part of its offering, though the core traction appears to be in center-based care.
This is not a asset-light, software-as-a-service play. It requires significant capital for medical equipment, real estate, and clinical staffing. The funding to date reflects early investor confidence in this capital-intensive wedge. The Renal Project has raised a total of approximately $1.33 million across several pre-seed and seed rounds, with a notable January 2024 pre-seed investment led by the JITO Angel Network (JAN) [CB Insights-style profile, January 2024].
| Funding Round | Date | Amount | Lead Investor(s) |
|---|---|---|---|
| Pre-seed | August 2020 | $299,000 | Undisclosed |
| Seed | July 2023 | $370,000 | Undisclosed |
| Pre-seed | January 2024 | Undisclosed | JITO Angel Network (JAN) [CB Insights-style profile, January 2024] |
Navigating a crowded and complex landscape
The competitive field for renal care in India is dense, spanning large chains, niche providers, and international players. The Renal Project is not entering a green field. It faces competition from established dialysis service providers like NephroPlus and VitusCare, as well as a range of other domestic and international entities focused on various aspects of kidney disease management [Competitors list].
The company's most plausible answer to this competition is its targeted geography and capital-efficient scaling. By focusing on underserved Tier II and III cities with a micro-center model, it may avoid direct, costly competition with large chains concentrated in urban hubs. Furthermore, its use of in-house software for center management hints at an operational efficiency layer, though this is presented as an enabler for world-class management rather than a standalone product.
The risks here are substantial and familiar to any physical infrastructure play.
- Capital intensity. The model burns capital to build centers before achieving patient volume and revenue. The $1.33 million raised to date is likely just a starting point for meaningful network scale.
- Operational complexity. Managing clinical staff, supply chains, and patient care across distributed locations is a significant execution challenge, distinct from software scaling.
- Regulatory navigation. While adhering to Indian Society of Nephrology guidelines is a start, obtaining and maintaining all necessary state and central healthcare licenses for each new center is a persistent hurdle.
The standard of care, and the path forward
The patient population here is those with end-stage renal disease (ESRD), who require hemodialysis typically three times a week to filter waste from their blood. Without it, survival is measured in weeks. The standard of care in much of India today involves significant travel, high out-of-pocket costs, and overcrowded facilities in major cities. For many, it represents a catastrophic health expenditure that can push families into poverty.
The Renal Project's next twelve months will be about proving its unit economics and replication model. Key milestones to watch include the number of operational centers it can launch beyond its initial footprint, the publication of any patient volume or outcomes data, and the inevitable next fundraising round. Given the capital requirements, a Series A round to fund a more aggressive expansion seems a likely near-term goal.
Success won't be measured in monthly active users or software license counts, but in the number of patients who can receive treatment closer to home. For a population facing a lifelong, life-sustaining regimen, reducing the distance to care isn't just a convenience, it's a fundamental improvement in quality of life. The Renal Project is making a hard, physical bet that this gap is best addressed not with an app, but with a clinic.
Sources
- [CB Insights-style profile, January 2024] The Renal Project | https://www.cbinsights.com/company/the-renal-project
- [Startup directory, 2024] The Renal Project | https://www.18startup.com/company/the-renal-project
- [medicalstartups.org, October 2025] Top 30 Kidney Disease treatment startups (October 2025) | https://medicalstartups.org/top/kidney/
- [100X.VC, 2026] Shashank Moddhia - Profile Interview | https://www.100x.vc/blog/interview-with-shashank-moddhia-the-renal-project-
- [Fierce Healthcare, Unknown] New kidney care companies intend to make money by keeping patients out of the dialysis chair | https://www.fiercehealthcare.com/hospitals-health-systems/more-companies-invest-kidney-care-space
- [Healio, November 2025] How a kidney care startup moved from concept to FDA clearance | https://www.healio.com/news/nephrology/20251124/how-a-kidney-care-startup-moved-from-concept-to-fda-clearance